242 related articles for article (PubMed ID: 29311085)
1. The Rim Pathway Mediates Antifungal Tolerance in Candida albicans through Newly Identified Rim101 Transcriptional Targets, Including Hsp90 and Ipt1.
Garnaud C; García-Oliver E; Wang Y; Maubon D; Bailly S; Despinasse Q; Champleboux M; Govin J; Cornet M
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311085
[TBL] [Abstract][Full Text] [Related]
2. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.
Singh SD; Robbins N; Zaas AK; Schell WA; Perfect JR; Cowen LE
PLoS Pathog; 2009 Jul; 5(7):e1000532. PubMed ID: 19649312
[TBL] [Abstract][Full Text] [Related]
3. Genetic Analysis of
Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
[No Abstract] [Full Text] [Related]
4. The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance.
Shapiro RS; Zaas AK; Betancourt-Quiroz M; Perfect JR; Cowen LE
PLoS One; 2012; 7(9):e44734. PubMed ID: 22970302
[TBL] [Abstract][Full Text] [Related]
5. Extensive functional redundancy in the regulation of Candida albicans drug resistance and morphogenesis by lysine deacetylases Hos2, Hda1, Rpd3 and Rpd31.
Li X; Robbins N; O'Meara TR; Cowen LE
Mol Microbiol; 2017 Feb; 103(4):635-656. PubMed ID: 27868254
[TBL] [Abstract][Full Text] [Related]
6. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90.
LaFayette SL; Collins C; Zaas AK; Schell WA; Betancourt-Quiroz M; Gunatilaka AA; Perfect JR; Cowen LE
PLoS Pathog; 2010 Aug; 6(8):e1001069. PubMed ID: 20865172
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicans.
Li C; Tu J; Han G; Liu N; Sheng C
Eur J Med Chem; 2022 Jan; 227():113961. PubMed ID: 34742014
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 governs dispersion and drug resistance of fungal biofilms.
Robbins N; Uppuluri P; Nett J; Rajendran R; Ramage G; Lopez-Ribot JL; Andes D; Cowen LE
PLoS Pathog; 2011 Sep; 7(9):e1002257. PubMed ID: 21931556
[TBL] [Abstract][Full Text] [Related]
9. Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.
Lamoth F; Juvvadi PR; Soderblom EJ; Moseley MA; Asfaw YG; Steinbach WJ
Antimicrob Agents Chemother; 2014; 58(4):1889-96. PubMed ID: 24395240
[TBL] [Abstract][Full Text] [Related]
10. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
Jensen RH; Astvad KM; Silva LV; Sanglard D; Jørgensen R; Nielsen KF; Mathiasen EG; Doroudian G; Perlin DS; Arendrup MC
J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
[TBL] [Abstract][Full Text] [Related]
11. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
12. Geldanamycin confers fungicidal properties to azole by triggering the activation of succinate dehydrogenase.
Xiong J; Wang L; Feng Y; Zhen C; Hang S; Yu J; Lu H; Jiang Y
Life Sci; 2024 Jul; 348():122699. PubMed ID: 38718854
[TBL] [Abstract][Full Text] [Related]
13. Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans.
Xu Y; Lu H; Zhu S; Li WQ; Jiang YY; Berman J; Yang F
Microbiol Spectr; 2021 Sep; 9(1):e0032121. PubMed ID: 34160280
[TBL] [Abstract][Full Text] [Related]
14. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
15. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
[TBL] [Abstract][Full Text] [Related]
16. Deletions of the endocytic components VPS28 and VPS32 in Candida albicans lead to echinocandin and azole hypersensitivity.
Cornet M; Gaillardin C; Richard ML
Antimicrob Agents Chemother; 2006 Oct; 50(10):3492-5. PubMed ID: 17005841
[TBL] [Abstract][Full Text] [Related]
17. Hsp21 potentiates antifungal drug tolerance in Candida albicans.
Mayer FL; Wilson D; Hube B
PLoS One; 2013; 8(3):e60417. PubMed ID: 23533680
[TBL] [Abstract][Full Text] [Related]
18. Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations.
Hill JA; Ammar R; Torti D; Nislow C; Cowen LE
PLoS Genet; 2013 Apr; 9(4):e1003390. PubMed ID: 23593013
[TBL] [Abstract][Full Text] [Related]
19. Deletions of endocytic components VPS28 and VPS32 affect growth at alkaline pH and virulence through both RIM101-dependent and RIM101-independent pathways in Candida albicans.
Cornet M; Bidard F; Schwarz P; Da Costa G; Blanchin-Roland S; Dromer F; Gaillardin C
Infect Immun; 2005 Dec; 73(12):7977-87. PubMed ID: 16299290
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
Liu TT; Lee RE; Barker KS; Lee RE; Wei L; Homayouni R; Rogers PD
Antimicrob Agents Chemother; 2005 Jun; 49(6):2226-36. PubMed ID: 15917516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
